Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components (Details) - Schedule of accrued liabilities

v3.22.2.2
Balance Sheet Components (Details) - Schedule of accrued liabilities - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Schedule Of Accrued Liabilities Abstract    
Accrued labor costs $ 1,823 $ 691
Accrued drug development costs 1,115 369
Other 127 152
Total $ 3,065 $ 1,212